¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"dreamy state epilepsy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sensory epilepsy
    °¨°¢°£Áú
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • temporal lobe epilepsy
    °üÀÚ¿±°£Áú, ÃøµÎ¿±°£Áú
  • tardy epilepsy
    ¸¸±â°£Áú
  • anxiety state
    ºÒ¾È»óÅÂ
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • basal state
    ±âÃÊ»óÅÂ
  • clouded state
    ȥŹ»óÅÂ
  • condensed state
    ÃàÇÕ»óÅÂ
  • correlated state
    »ó°ü»óÅÂ
  • critical state
    ÀÓ°è»óÅÂ
  • carrier state
    º¸±Õ»óÅÂ
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
  • dynamic state
    ¿ªµ¿»óÅÂ
  • dormant state
    Àẹ»óÅÂ, ÀáÀç»óÅÂ, ÈÞ¸é»óÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • psychomotor epilepsy
    Á¤½Å¿îµ¿°£Áú
  • reflex epilepsy
    ¹Ý»ç°£Áú
  • retrocursive epilepsy
    ÈÄÅð°£Áú
  • running epilepsy
    ÁúÁÖ°£Áú
  • senile epilepsy
    ³ëÀΰ£Áú
  • sensory epilepsy
    °¨°¢°£Áú
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • somnambulistic epilepsy
    ¸ùÀ¯º´°£Áú
  • tardy epilepsy
    Áß³âÀÌÈİ£Áú
  • verbomotor epilepsy
    ´Ùº¯¼º°£Áú
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼ºÈ¥µ·»óÅÂ
  • adult ego state
    ¼ºÀÎÀھƻóÅÂ
  • alcoholic paranoid state
    ¾ËÄÚ¿ÃÆíÁý»óÅÂ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • SSFP ( steady state free precession)
    Ç×Á¤ »óÅ ÀÚÀ¯ ¼¼Â÷
  • accessory state
    µ¡»óÅÂ
  • acute confusional state
    ±Þ¼º È¥µ· »óÅÂ
  • adult ego state
    ¼ºÀÎ ÀھƻóÅÂ
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ(ÊÙË×̬).
  • allergic state
    ¾Ë·¹¸£±â»óÅÂ, °ú¹Î»óÅÂ
  • anxiety state
    ºÒ¾È»óÅÂ.
  • anxiety tension state
    ºÒ¾È, ±äÀå»óÅÂ(ÑÌíåßÒ÷¾).
  • ground state
    ±âÀú»óÅÂ(Ðñî¼ßÒ÷¾).
  • hepatitis,carrier state
    º¸±ÕÀÚ(ÜÁжíº)
  • hypercoagulable state
    °úÀÀ°í»óÅÂ
  • hyperdynamic state
    °ú¿ªµ¿»óÅÂ.
  • hyperimmune state
    °ú¸é¿ª»óÅÂ.
  • hyperimmune state
    °ú¸é¿ª»óÅÂ.
  • hyperkinetic circulatory state
    ¿îµ¿°úÀ×¼º ¼øÈ¯»óÅÂ(¡­âàü»ßÒ÷¾).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • hiernosus =epilepsy
    °£Áú(ÊÖòð).
  • hysterical epilepsy
    È÷½ºÅ׸®¼º °£Áú
  • idiopathic epilepsy
    Ư¹ß¼º °£Áú.
  • juvenile myoclonic epilepsy
    û¼Ò³â±Ù°£´ë¼º°£Áú(~ÐÉÊàÓÛàõÊÖòð)
  • laryngeal epilepsy
    Èĵμº Çö±â(¡­úßѨ).
  • latent epilepsy
    Àẹ°£Áú(íÖÜÑÊÖòð).
  • limbic epilepsy personality syndrome
    º¯¿¬°è°£ÁúÀΰÝÁõÈıº(Ü«æÞÍ£ÊÖòðìÑÌ«ñøý¦ÏØ)
  • local epilepsy
    ±¹¼Ò°£Áú(¡­ÊÖòð).
  • major epilepsy
    ´ë°£Áú(ÓÞÊÖòð).
  • masked epilepsy
    °¡¸é°£Áú(Ê£ØüÊÖòð).
  • menstrual epilepsy
    ¿ù°æ¼º °£Áú(¡­ÊÖòð).
  • minor epilepsy
    ¼Ò°£Áú(á³ÊÖòð).
  • morpheic epilepsy
    ¼ö¸éÇü°£Áú(â²Øùû¡ ÊÖòð).
  • myoclonic epilepsy
  • myoclonic epilepsy and raggedred fibers
    °£´ë±ÙÀ°°æ·Ã¼º°£Áú(ÊàÓÛÐÉë¿ÌâÕýàõÊÖòð)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • transition state theory
    õÀÌ »óÅ ÀÌ·Ð(ôÃì¹ßÒ÷¾×âÖå)
  • triplet state
    »ïÁßÀÚ »óÅÂ(ß²ñìí­ßÒ÷¾)
  • triploid state
    »ï¹è¼ö »óÅÂ(ß²ÛÃâ¦ßÒ÷¾)
  • two-state model
    ¾ç»ó(å»ßÒ)¸ðµ¨
  • vegetative state
    Áõ½Ä(ñòãÖ) »óÅÂ(ßÒ÷¾)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
EFA Epilepsy Foundation of America; essential fatty acid; extrafamily adoptee
EPI echo planar imaging; electronic portal imaging; Emotion Profile Index; epilepsy; epinephrine; epithe...
epil epilepsy, epileptic
GE gastric empyting; gastroemotional; gastroenteritis; gastroenterology; gastroenterostomy; gastroesoph...
GM gastric mucosa; Geiger-Muller [counter]; general medicine; genetic manipulation; geometric mean; gia...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
JME Juvenile Myoclonic Epilepsy
JAE Juvenile absence epilepsy
MTLE Medial temporal lobe epilepsy
MERRF Myoclonic Epilepsy and Ragged Red Fibers
MERRF Myoclonic epilepsy with ragged-red fibers
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • index of occlusal state
    ±³ÇÕ »óÅ Áö¼ö
  • lacunar state
    ¿­°ø »óÅÂ
  • latent state
    ÀáÀç »óÅÂ
    Àẹ±âÀÇ ±ÕÀÇ »óÅÂ. ±Õ ÀÚ½ÅÀÇ º´Àû Ư¼ºÀ» ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖ´Â »óÅÂ.
  • open state
    °³¹æ »óÅÂ
  • ordinary state
    »óÅÂ
  • paranoid state
    ÆíÁý »óÅÂ
  • partial saturation state
    ºÎºÐ Æ÷È­ »óÅÂ
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
  • posthypercapnic state
    ÈÄ °úź»êÁõ »óÅÂ
  • relaxation state
    ÀÌ¿Ï »óÅÂ
  • saturation state
    Æ÷È­ »óÅÂ
  • schizophrenic defective state
    ºÐ¿­Áõ °áÇÔ »óÅÂ
    º´¼¼°¡ Á¤ÁöÇÏ¿© Àΰݿ¡ Áö¼ÓÀûÀÎ °áÇÔÀ» ³²±â´Â °æ¿ì.
  • schizophrenic state
    ºÐ¿­ »óÅÂ, Á¤½Å ºÐ¿­ »óÅÂ
  • solid-state laser
    °íü ·¹ÀÌÀú
    °íü ¹°ÁúÀÌ µµÆ÷µÈ º¸Åë ¹Ì·® ¿ø¼Ò·Î °áÁ¤ ¼ÒÁÖ¸¦ Ȱ¼º ¸ÅÁú·Î »ç¿ëÇÏ´Â ·¹ÀÌÀú. 2±Ø Áø°ø°ü ¶Ç´Â ¹ÝµµÃ¼ ·¹ÀÌÀú´Â º¸Åë °íü ·¹ÀÌÀú¶ó´Â Á¤ÀÇ¿¡ ÀûÇÕÇÏÁö¸¸ ÀÌ ±º¿¡¼­ Á¦¿ÜµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
state government The complex of political institutions, laws, and customs through which the function of governing the state is carried out (u.s. Only).
(12 Dec 1998)
state health planning and development agencies Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council.
(12 Dec 1998)
state health plans State plans prepared by the state health planning and development agencies which are made up from plans submitted by the health systems agencies and subject to review and revision by the statewide health coordinating council.
(12 Dec 1998)
state hospital A hospital supported in part by taxpayers and administered by state government officials.
(05 Mar 2000)
state implementation plan A state plan required by the Clean Air act to bring nonattainment areas into compliance with federal ambient air quality standards.
(05 Dec 1998)
state medicine A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population.
(12 Dec 1998)
steady state A dynamic equilibrium.
(13 Nov 1997)
steady-state rate The velocity of an enzyme-catalyzed reaction in which, over the time course of the study, the concentration of any enzyme species is constant (i.e., for an enzyme-substrate binary complex, ES, d[ES]/dt&apprxeq;00; for this to hold true, the total enzyme concentration must be much less than the initial substrate concentration.
Synonym: steady-state rate.
(05 Mar 2000)
steady-state velocity The velocity of an enzyme-catalyzed reaction in which, over the time course of the study, the concentration of any enzyme species is constant (i.e., for an enzyme-substrate binary complex, ES, d[ES]/dt&apprxeq;00; for this to hold true, the total enzyme concentration must be much less than the initial substrate concentration.
Synonym: steady-state rate.
(05 Mar 2000)
decerebrate state A peculiar neurologic condition elicited in vertebrates as a consequence of the elimination of brain function by transecting the brainstem or interrupting function by other techniques. Clinically, brain damage can result in neurological signs resembling those of a decerebrate animal. The state consists of exaggerated postures, grossly abnormal reflexes, convulsions, and extreme muscular rigidity and spasticity.
(12 Dec 1998)
decorticate state A unilateral or bilateral postural change, consisting of the upper extremities flexed and adducted and the lower extremities in rigid extension; due to structural lesions of the thalamus, internal capsule, or cerebral white matter.
Synonym: decorticate state.
(05 Mar 2000)
imperfect state In fungi, the state or stage at which only asexual spores such as conidia are formed; most such species are classified as Deuteromycetes (Fungi Imperfecti).
(05 Mar 2000)
transition state The activated state of a molecule that has partly undergone a chemicalreaction.
(09 Oct 1997)
transition state intermediate In a chemical reaction, an unstable and high-energy configuration assumed by reactants on the way to making products. Enzymes are thought to bindand stabilise the transition state, thus lowering the energy of activation needed to drive the reaction to completion.
(09 Oct 1997)
triplet state A second excited state of a molecule (e.g., chlorophyll) produced by absorption of light to produce the singlet state, then loss of some energy (fluorescence) to arrive at the longer-lived triplet state The molecule may remain sufficiently long in the triplet state for a second activating light quantum to be effective in producing a "second triplet" state, obviously at still a higher level of excitation, hence reactivity. Alternatively, it may lose the triplet state energy directly and return to the ground state.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Gopher State
    x;¹Ì±¹ Minnesota wndml thrcld
  • Grand Canyon State
    ¹Ì±¹ ArizoaÁÖÀÇ ¼ÓĪ
  • Granite State
    ¹Ì±¹ New HampshireÁÖÀÇ ¼ÓĪ
  • Green Mountain State
    vermont ÁÖÀÇ ¼ÓĪ
  • Hawkeyed State
    IowaÁÖÀÇ µý À̸§
  • Hoosier State
    IndianaÁÖÀÇ ¼ÓĪ
  • Irish Free State
    ¾ÆÀÏ·£µå ÀÚÀ¯±¹)
  • Keystone state
    Ææ½Çº£À̴ϾÆÁÖÀÇ µý À̸§
  • Lake State
    ¹Ì±¹ÁÖÀǺ°Äª
  • Magnolia State
    Mississippi ÁÖÀÇ ¼ÓĪ
  • Mother State
    VirginiaÁÖÀÇ
  • Negro state
    (³²ºÏ ÀüÀï ÀÌÀüÀÇ ³²ºÎÀÇ ³ë¿¹ÁÖ
  • New York State Barge Canal
    ´º¿åÁê ¿îÇϸÁ
  • North Star State
    MinnesotaÁÖÀÇ ¼ÓĪ
  • Nutmeg state
    ¹Ì±¹ ConnecticutÁÖÀÇ ¼ÓĪ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á